Erythematous Papules and Plaques in an Infant Receiving Glucagon Therapy
JEADV Clinical Practice, EarlyView.
Sara Al Janahi +4 more
wiley +1 more source
EPITHELIOMA, ERYTHEMA INDURATUM (?), AND ULTRA-VIOLET RADIATION [PDF]
, 1928 J. G. Tomkinson
openalex +1 more source
JEADV Clinical Practice, EarlyView.Multiple cutaneous manifestations have been linked with COVID‐19, including cutaneous vasculitis, ranging from mild or asymptomatic to fulminant. We conducted a comprehensive study investigating the cutaneous and histopathological manifestations of vasculitis in 33 patients with COVID‐19.
Reem Diab +8 more
wiley +1 more source
Lupus Erythematosus of the Scalp, Associated with Scars of Old Papulo-Necrotic Tuberculide Lesions and of Erythema Induratum on the Arms and Legs [PDF]
, 1927 H. W. Barber
openalex +1 more source
Comparison of Topical 20% Azelaic Acid and 7.5% Dapsone in the Treatment of Mild-To-Moderate Papulopustular Rosacea. [PDF]
J Cosmet DermatolHasanbeyzade S.
europepmc +1 more source
Persistent Erythema, with Ischæmic Circulation in the Left Foot, Possibly in Part Connected with Prolonged Use of a Plaster Bandage for Tuberculous Disease of the Left Knee [PDF]
, 1927 Fabian Weber
openalex +1 more source
The Rare Presentation of Deep Dermatophytosis‐Trichophyton in an Immunosuppressed Patient
JEADV Clinical Practice, EarlyView.ABSTRACT Dermatophytes typically cause superficial skin infections characterized by an active border. However, they can present atypically invading deeper in immunocompromised patients. We present a case of a 72‐year‐old woman with bullous pemphigoid who had received oral prednisolone for 3 months and developed umbilicated papules.
Jidapa Triwatcharikorn +3 more
wiley +1 more source
Severe Drug-Induced Dermatosis in a Geriatric Patient: A Case Report. [PDF]
CureusSaldaña Guerrero S +2 more
europepmc +1 more source
JEADV Clinical Practice, EarlyView.Capsule Summary Generalised pustular psoriasis is one of the severe dermatological disorders. The use of biologics in psoriatic patients with end‐stage renal disease is rare, and the safety information on biologics treatment in such patients is limited.
Yasuyuki Fujita +4 more
wiley +1 more source